Cargando…

COVID-19 case-fatality variations with application to the Middle East countries

During a pandemic outbreak, it is important for health officials to know the proportions of deaths among infected individuals and to understand how these proportions change overtime, to accurately predict the impact of the pandemic and to implement effectively new intervention policies and health pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Khedhiri, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966859/
https://www.ncbi.nlm.nih.gov/pubmed/35378737
http://dx.doi.org/10.1007/s10708-022-10635-2
_version_ 1784678723432218624
author Khedhiri, Sami
author_facet Khedhiri, Sami
author_sort Khedhiri, Sami
collection PubMed
description During a pandemic outbreak, it is important for health officials to know the proportions of deaths among infected individuals and to understand how these proportions change overtime, to accurately predict the impact of the pandemic and to implement effectively new intervention policies and health protocols and to adjust them accordingly. However, most studies where efforts have been made to estimate accurately the case fatality rates did not address the issue of measuring the dynamics of the pandemic deadliness during its course. Daily data on COVID-19 cases and deaths were collected from selected MENA countries. In this paper, two new measures of the pandemic fatality are developed based on the estimated time it takes hospitalized infected patients to eventually die from the disease. The first measure assigns COVID-19 deaths to its most significant lagged number of cases based on a fixed-effects panel data model. The second fatality measure relates pandemic deaths and cases based on their respective change points. The results find notable variations of the pandemic lethality between the Middle East countries, likely due to the difference in the quality of health care. Although crude case-fatality rate does not identify the pandemic lethality variations during the ongoing of the disease, this paper develops two novel measures for COVID-19 case fatality which can identify the dynamics and the variations of the pandemic deadliness.
format Online
Article
Text
id pubmed-8966859
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-89668592022-03-31 COVID-19 case-fatality variations with application to the Middle East countries Khedhiri, Sami GeoJournal Article During a pandemic outbreak, it is important for health officials to know the proportions of deaths among infected individuals and to understand how these proportions change overtime, to accurately predict the impact of the pandemic and to implement effectively new intervention policies and health protocols and to adjust them accordingly. However, most studies where efforts have been made to estimate accurately the case fatality rates did not address the issue of measuring the dynamics of the pandemic deadliness during its course. Daily data on COVID-19 cases and deaths were collected from selected MENA countries. In this paper, two new measures of the pandemic fatality are developed based on the estimated time it takes hospitalized infected patients to eventually die from the disease. The first measure assigns COVID-19 deaths to its most significant lagged number of cases based on a fixed-effects panel data model. The second fatality measure relates pandemic deaths and cases based on their respective change points. The results find notable variations of the pandemic lethality between the Middle East countries, likely due to the difference in the quality of health care. Although crude case-fatality rate does not identify the pandemic lethality variations during the ongoing of the disease, this paper develops two novel measures for COVID-19 case fatality which can identify the dynamics and the variations of the pandemic deadliness. Springer Netherlands 2022-03-30 2023 /pmc/articles/PMC8966859/ /pubmed/35378737 http://dx.doi.org/10.1007/s10708-022-10635-2 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Khedhiri, Sami
COVID-19 case-fatality variations with application to the Middle East countries
title COVID-19 case-fatality variations with application to the Middle East countries
title_full COVID-19 case-fatality variations with application to the Middle East countries
title_fullStr COVID-19 case-fatality variations with application to the Middle East countries
title_full_unstemmed COVID-19 case-fatality variations with application to the Middle East countries
title_short COVID-19 case-fatality variations with application to the Middle East countries
title_sort covid-19 case-fatality variations with application to the middle east countries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966859/
https://www.ncbi.nlm.nih.gov/pubmed/35378737
http://dx.doi.org/10.1007/s10708-022-10635-2
work_keys_str_mv AT khedhirisami covid19casefatalityvariationswithapplicationtothemiddleeastcountries